Loading...
Loading...
Among the 3 tracked institutional investors we monitor, MBRX (MOLECULIN BIOTECH INC) is held with a combined value of $52.58K across 16,038 shares. The largest holder is VANGUARD GROUP INC with a position worth $51.45K. 2 funds opened new positions in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$52.58K
Total Shares Held
16,038
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $51.45K | 0.00% | New |
| 2 | BlackRock, Inc. | $1.12K | 0.00% | -0.8% |
| 3 | FMR LLC | $7 | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of MBRX with a position worth $51.45K, representing 0.00% of their portfolio. In total, 3 institutional investors hold MBRX with a combined value of $52.58K.
In the most recent quarter, 2 funds opened a new position in MBRX. Additionally, 1 reduced their positions.
Institutional investors hold $52.58K worth of MBRX stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $51.45K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MBRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MBRX positions.
Last Close
$2.19
2026-07-27
YTD
-39.5%
1% of 52-week range